Contributor Page
Ropes & Gray LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 5969000
Fax: +1 212 5969090
1211 Avenue of the Americas
New York
NY 10036-8704
United States
By Martin Crisp, Douglas Hallward-Driemeier, David B. Hennes
On December 3, 2018, the U.S. Supreme Court heard oral argument in Lorenzo v. SEC, which involves an attempt by the SEC to use a "scheme liability" theory under Section 10(b) of the Exchange Act ...
By Scott A. McKeown
As I predicted a few weeks back, the Patent Trial & Appeal Board is now moving Proppant Express Investments, LLC, Proppant Express Solutions, LLC v. Oren Technologies, LLC, (IPR2018-00914) to the Precedential Opinion Panel (POP).
By Ropes & Gray LLP's FDA Regulatory Practice, Ropes & Gray LLP's Digital Health Practice Group
As such, the software output would be subject to FDA's regulations for FDA required labeling or promotional labeling, as applicable.
By Ama Adams, Brendan Hanifin, Emerson Siegle
The Société Générale settlement illustrates that U.S. sanctions enforcement is alive and well, despite below average enforcement activity year to date.
By Scott A. McKeown
For those seeking Patent Trial & Appeal Board (PTAB) related CLE/programming this month, the PTAB itself is hosting a Boardside Chat webinar this Thursday,
By Ropes & Gray LLP's Securities & Public Companies Practice, Ropes & Gray LLP's Executive Compensation & Employee Benefits Practice
Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co. (Glass Lewis) have both released updates to their proxy voting guidelines
By Ryan Rohlfsen, Patrick J. Reinikainen, Christopher Nienhaus
On November 29, 2018, Deputy Attorney General Rod J. Rosenstein delivered remarks at the American Conference Institute's 35th International Conference on the Foreign Corrupt Practices Act.
By Scott A. McKeown
Efficiency Considerations Determined at the Time of Institution
By Kat Saunders Gregor
Hi, I'm Kat Gregor, and I am a tax partner in Ropes and Gray's Boston office.
By Ropes & Gray LLP's Health Care Practice
On November 15, 2018, the U.S. FDA published a proposed rule1 that would allow IRBs to waive or alter informed consent when a clinical investigation poses no more than minimal risk to, and includes appropriate safeguards...
By Isabelle Farrar, Kat Saunders Gregor
August 2018 brought two major developments in the Department of Treasury's race to finalize its partnership audit reform regulations before partnerships begin in early 2019 filing tax returns for the first time under the new regime.
By Michael Littenberg
Corporate social responsibility disclosure and compliance is an increasing area of focus for many in-house legal departments.
By Scott A. McKeown
In deciding the meaning of this term the Court reviewed the record of earlier concluded IPR proceedings.
By Ropes & Gray LLP's Health Care Practice
On November 21 and 23, 2018, the Centers for Medicare & Medicaid Services ("CMS") finalized rules reinforcing a developing trend away from delivery of care in traditional inpatient care settings.
By Ropes & Gray LLP's Health Care Practice
On November 1, 2018, the CMS released a proposed rule, available here, that updates requirements of the MA program, also known as Medicare Part C, and the Medicare Prescription drug benefit program.
Contributor's Topics